Neurocrine Biosciences reported $2.14B in Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acadia Pharmaceuticals ACAD:US USD 602.49M 10.28M
Acorda Therapeutics ACOR:US USD 393.34M 12.97M
Agios Pharmaceuticals AGIO:US USD 1.18B 72.15M
ALKERMES ALKS:US USD 1.94B 15.52M
Alnylam Pharmaceuticals ALNY:US USD 3.54B 204.84M
Amgen AMGN:US USD 63.7B 4.41B
Aptinyx Inc APTX:US USD 76.2M 16.1M
Biogen BIIB:US USD 24.85B 227.2M
Biomarin Pharmaceutical BMRN:US USD 6.26B 118.2M
Cytokinetics CYTK:US USD 1.08B 304.24M
Dynavax Technologies DVAX:US USD 999.34M 23.66M
Enanta Pharmaceuticals ENTA:US USD 375.41M 9.8M
Exelixis EXEL:US USD 2.96B 79.97M
Gilead Sciences GILD:US USD 62.56B 313M
Halozyme Therapeutics HALO:US USD 1.86B 83.15M
Intercept Pharmaceuticals ICPT:US USD 559.4M 60.81M
Intra Cellular Therapies ITCI:US USD 782M 29.91M
IONIS PHARMACEUT IONS:US USD 2.42B 34.16M
Nektar Therapeutics NKTR:US USD 781.01M 80.98M
Neurocrine Biosciences NBIX:US USD 2.14B 137.7M
Prothena PRTA:US USD 554.44M 4.85M
Regeneron Pharmaceuticals REGN:US USD 27.68B 472M
Repligen RGEN:US USD 2.46B 17.62M
Sarepta Therapeutics SRPT:US USD 3.16B 159.3M
Teva Pharmaceutical TEVA:IT USD 44.25B 1.68B
Ultragenyx Pharmaceutical RARE:US USD 1.62B 297.85M
Vertex Pharmaceuticals VRTX:US USD 16.71B 1.12B
Xoma XOMA:US USD 146.13M 8.09M
YTE INCY:US USD 5.51B 191.18M